Log in to save to my catalogue

Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives

Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_809aa2bea689405d8725df5a8b15aaf8

Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives

About this item

Full title

Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives

Publisher

England: BioMed Central Ltd

Journal title

Journal of hematology and oncology, 2024-08, Vol.17 (1), p.68-42, Article 68

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Cuproptosis is a newly identified form of cell death induced by excessive copper (Cu) accumulation within cells. Mechanistically, cuproptosis results from Cu-induced aggregation of dihydrolipoamide S-acetyltransferase, correlated with the mitochondrial tricarboxylic acid cycle and the loss of iron-sulfur cluster proteins, ultimately resulting in pr...

Alternative Titles

Full title

Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_809aa2bea689405d8725df5a8b15aaf8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_809aa2bea689405d8725df5a8b15aaf8

Other Identifiers

ISSN

1756-8722

E-ISSN

1756-8722

DOI

10.1186/s13045-024-01589-8

How to access this item